Autres langues BioHarvest Sciences Inc. Canadian Securities Exchange

Actions

BHSC

CA13767B1013

Produits pharmaceutiques

Temps Différé Canadian Securities Exchange 16:24:58 05/10/2021			Varia. 5j.	Varia. 1 janv.
0,3500 ^CAD	+6,06%		-2,94%	+46,67%

11/08	Transcript : BioHarvest Sciences Inc., Q2 2026 Earnings Call, Aug 11, 2026
11/08	BioHarvest Sciences Inc. révise ses prévisions de résultats consolidés pour l'exercice 2026	CI

Autres langues

13:02	BioHarvest Sciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
03/09	BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)
11/08	BioHarvest Sciences Inc. Revises Consolidated Earnings Guidance for the Fiscal Year 2026
11/08	BioHarvest Sciences Inc Secures 20-Ton Manufacturing And Supply Agreement For Rare Botanical Luxury Fragrance With Undisclosed UAE-Based Customer
11/08	BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update
11/08	BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance
11/08	BioHarvest Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
29/07	BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference
28/07	BioHarvest Sciences to Report Second Quarter 2026 Financial Results on August 11, 2026
15/07	BioHarvest Sciences Inc. Receives $1.4 Million Grant from the Israel Innovation Authority to Pioneer AI-Driven Plant-Cell Synthesis
15/07	BioHarvest Awarded $1.4M Grant from the Israel Innovation Authority to Pioneer AI-Driven Plant-Cell Synthesis
14/07	BioHarvest Sciences to Participate in the 'Health, Wellness & Longevity' Virtual Conference Presented by Maxim Group LLC
13/07	BioHarvest Sciences : to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC
13/07	BioHarvest Sciences to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC
18/06	BioHarvest Sciences to Present at the 2026 BIO International Convention
18/05	Tate & Lyle And BioHarvest Sciences Expand Collaboration For Next-Generation Plant-Based Sweetener Molecule Development
18/05	Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation
14/05	BioHarvest Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
14/05	BioHarvest Sciences : First Quarter 2026 Financial Statements
14/05	BioHarvest Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
13/05	BioHarvest Sciences Appoints New Head of Business Development for its CDMO Division
13/05	BioHarvest Sciences Inc. Announces Successful Completion Of Stage 1 Development Of Saffron Composition For Nutraceutical And Culinary Applications
13/05	BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications
12/05	BioHarvest Sciences Signs $1.2 Million CDMO Stage2 Contract for the Development of A Rare Fragrance Using Its Proprietary Botanical Synthesis Platform
12/05	BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform